Average Co-Inventor Count = 7.20
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (20 from 1,454 patents)
2. Sanofi-aventis (1 from 389 patents)
21 patents:
1. 11725036 - Modified lipidated relaxin B chain peptides and their therapeutic use
2. 10988523 - Modified lipidated Relaxin B chain peptides and their therapeutic use
3. 10988524 - Modified relaxin B chain peptides and their therapeutic use
4. 10980816 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
5. 10961295 - Modified lipidated Relaxin B chain peptides and their therapeutic use
6. 10736904 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
7. 10500212 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
8. 10220044 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
9. 9744176 - Therapeutic uses of novel thienopyrimidine derivatives
10. 9675606 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
11. 9169246 - Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
12. 9126972 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
13. 9115140 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
14. 8975250 - 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
15. 8846712 - 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors